What is MD Longevity?
MD Longevity Clinic is a distinguished provider of anti-aging and age management medicine, with a particular focus on bioidentical hormone replacement therapy. Operating out of New York, the clinic, under the leadership of Dr. Ann Peters, leverages regenerative medicine to craft personalized treatment plans. These services are designed to enhance health, wellness, and overall quality of life for clients seeking to mitigate the effects of aging and regain vitality.
How much funding has MD Longevity raised?
MD Longevity has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for MD Longevity?
With significant Series B/C stage backing, MD Longevity is poised for accelerated growth and market expansion. The recent influx of capital is expected to fuel strategic initiatives, potentially including the enhancement of service offerings, broader client outreach, and further development of their regenerative medicine protocols. This investment signals strong confidence in the clinic's business model and its capacity to address the growing demand for advanced anti-aging solutions.
See full MD Longevity company page
